MEDNAX Reports Third Quarter Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to MEDNAX Reports Third Quarter Results

MEDNAX (MD) Tops Q3 EPS by 1c, Revenues Beat; Offers Q4 EPS Outlook

November 1, 2019 6:01 AM EDT

MEDNAX (NYSE: MD) reported Q3 EPS of $0.91, $0.01 better than the analyst estimate of $0.90. Revenue for the quarter came in at $889 million versus the consensus estimate of $876.24 million.

For the 2019 third quarter, MEDNAX reported the following results from continuing operations:

Net revenue of $889 million;GAAP net loss of $1.26 billion; andAdjusted EBITDA of $133 million.

Our operating results for the third quarter were in line with our expectations, said Roger J. Medel, M.D., Chief Executive Officer of MEDNAX. Revenue growth reflected strong patient volumes across our core medical groups, while clinical and... More